Drug Interactions in the Treatment of Malignancy in HIV-Infected Patients

Publisher： Karger

E-ISSN： 2296-5262|40|3|120-127

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.40, Iss.3, 2017-02, pp. : 120-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Candidal Meningitis in HIV-infected Patients: Treatment with Fluconazole

By Rodríguez-Arrondo F.   Aguirrebengoa K.   De Arce A.   Arrizabalaga J.   Iribarren J.A.   Von Wichmann M.A.   Goenaga M.A.  

Scandinavian Journal of Infectious Diseases, Vol. 30, Iss. 4, 1998-09 ,pp. : 417-418

Informa Healthcare

Access to resources Recommend Favorite

Osteoporosis in HIV-infected patients

By Groger Richard   Quirk Erin   Powderly William  

Clinical Review in Bone and Mineral Metabolism, Vol. 2, Iss. 2, 2004-06 ,pp. : 167-173

Humana Press, Inc

Access to resources Recommend Favorite

Miltefosine for visceral leishmaniasis relapse treatment and secondary prophylaxis in HIV-infected patients

By Marques Nuno   Sa Rosa   Coelho Filomena   Oliveira Joaquim   Saraiva Da Cunha J.   Melico-Silvestre A.  

Scandinavian Journal of Infectious Diseases, Vol. 40, Iss. 6-7, 2008-01 ,pp. : 523-526

Informa Healthcare

Access to resources Recommend Favorite

Population pharmacokinetics of dolutegravir in HIV‐infected treatment‐naive patients

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 3, 2015-09 ,pp. : 502-514

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epidemiology of Transmitted Drug Resistance in Chronically HIV-Infected Patients in Germany: The RESINA Study 2001–2009

By  

Intervirology, Vol. 55, Iss. 2, 2012-01 ,pp. : 154-159

Karger

Access to resources Recommend Favorite